Argan, Inc.
331.03USD
+0.7300 (+0.22%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on AGX.
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | 455.0M | 573.3M | 874.2M | 944.6M | 1.4B | 1.7B |
| Q1 | 100.3M | 103.7M | 157.7M | 193.7M | 291.0M | — |
| Q2 | 118.1M | 141.3M | 227.0M | 237.7M | 384.0M | — |
| Q3 | 117.9M | 163.8M | 257.0M | 251.2M | 358.8M | — |
| Q4 | 118.8M* | 164.6M* | 232.5M* | 262.1M* | 367.3M | — |
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | 2.33 | 2.39 | 6.15 | 9.74 | 13.27 | 16.11 |
| Q1 | .500 | .160 | .580 | 1.60 | 3.24 | — |
| Q2 | .300 | .940 | 1.31 | 2.50 | 3.76 | — |
| Q3 | .560 | .400 | 2.00 | 2.17 | 3.17 | — |
| Q4 | .962* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| .887* |
| 2.26* |
| 3.48* |
| 3.20 |
| — |
Debt level and coverage